The Navarro Pharmacy chain is owned by one of America’s largest pharmaceutical companies and operates more than 100 stores.

The chain has been struggling since the beginning of the year when it had a $1.5 million loss in March.

In an interview with Reuters last week, Navarro CEO and president James A. McBride said the company was taking a “hard look” at its business and said it was “actively working to mitigate its impacts on the community.”

“The bottom line is our business is performing well,” McBride told Reuters.

He said the chain’s losses are expected to be lower than its forecast in the third quarter of 2018, which will be the final quarter of the Trump administration.

The stock was up by about 6% in after-hours trading on Wednesday, to $8.19.